UMIN ID: UMIN000022334
Registered date:18/05/2016
Factual investigation on glaucoma
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Glaucoma |
| Date of first enrollment | 2016/05/19 |
| Target sample size | 400 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | The factor which participates in glaucoma |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Not applicable |
Related Information
| Primary Sponsor | Yoshikawa Eye Clinic |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Santen Pharmaceutical Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Keiji Yoshikawa |
| Address | 1-3-1 Nakamachi, Machida, Tokyo Japan 194-0021 |
| Telephone | 042-739-0781 |
| yoshi0781.auge@gmail.com | |
| Affiliation | Yoshikawa Eye Clinic Yoshikawa Eye Clinic |
| scientific contact | |
| Name | 1. Keiji Yoshikawa 2. Masayo Hashimoto |
| Address | 1. 1-3-1 Nakamachi, Machida, Tokyo 2. 4-20 Ohukacho, Kitaku, Osaka Japan |
| Telephone | 042-739-0781 |
| yoshi0781.auge@gmail.com | |
| Affiliation | 1. Yoshikawa Eye Clinic 2. Santen Pharmaceutical Co., Ltd. 1. Yoshikawa Eye Clinic 2. Japan Medical Affairs Medical Affairs Global R&D |